Patents limit medical potential of sequencing [6]

Nature

Volumn 419, Issue 6910, 2002, Pages 878-

  Merz, Jon F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; COST; DRUG INDUSTRY; GENOME; LETTER; LICENSING; PATENT; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0037206856     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/419878d     Document Type: Letter

References (4)

1. http://www.nature.com/nsu/O20923/O20923-2.html; 24 September 2002
2. Schissel, A., Merz, J F. & Cho, M. K. Nature 402, 118 (1999).
3. Merz, J. F., Kriss, A. G., Leonard, D. G. B. & Cho, M. K. Nature 415, 577-579 (2002).
4. Merz, J. E Clin. Chem. 45, 324-330(1999).